Logo
Dr. CYJ® Hair Filler (2 Syringe x 1ml Per Pack)

Dr. CYJ® Hair Filler (2 Syringe x 1ml Per Pack)

Dr. CYJ Hair Filler

Medical Device – Injectable Hair Filler
  • Class III CE Marked medical device (CE 2265) intended for injectable use in the scalp.
  • Manufactured by Caregen Co., Ltd. in accordance with applicable European medical device regulations and quality standards.
Peptide & Hyaluronic Acid Scalp Filler

Description

Dr. CYJ® Hair Filler is an advanced injectable treatment specifically developed to address hair loss and scalp concerns. Created by Caregen Co., Ltd., it is recognised as one of the first peptide-based hair fillers in the world. The clear, sterile gel combines hyaluronic acid with a patented complex of seven biomimetic peptides to stimulate hair follicles, improve scalp microcirculation, and support hair regrowth. Supplied as 2 x 1 ml pre-filled syringes, Dr. CYJ Hair Filler is injected into the scalp by qualified medical professionals to reduce hair thinning, strengthen existing hair, and enhance overall scalp health. The formulation is the result of many years of peptide research and is classified as a Class III CE-marked medical device for professional use.

Bnefits

  • Stimulates hair follicles and promotes hair regrowth in thinning areas.
  • Helps reduce hair loss and hair fall when used as part of a structured treatment protocol.
  • Improves hair density, thickness and overall hair quality over time.
  • Revitalises the scalp by enhancing local blood circulation and nourishing the hair follicles.
  • Uses seven patented biomimetic peptides combined with hyaluronic acid for targeted, long-lasting action in the scalp.
  • Supports regeneration and repair of scalp tissue damaged by chemical, physical or traumatic factors.
  • Suitable for both men and women experiencing early to moderate hair thinning or diffuse hair loss.
  • Non-surgical, minimally invasive in-clinic procedure with relatively short treatment sessions.

Indications

  • Androgenetic alopecia (male and female pattern hair loss) at mild to moderate stages.
  • Diffuse hair thinning and increased hair shedding.
  • Hair loss related to stress, ageing or environmental factors, where follicles remain viable.
  • Scalp damage and weakened hair follicles caused by chemical, physical or traumatic insults (e.g. aggressive cosmetic treatments, UV exposure).
  • Supportive treatment to improve scalp condition and hair quality alongside other hair-loss management strategies, as assessed by a clinician.

Composition

  • Hyaluronic acid 0.7% (non-animal origin).
  • Biomimetic peptides (seven patented peptides):
  • • Decapeptide-10
  • • Decapeptide-18
  • • Decapeptide-28
  • • Octapeptide-2
  • • Octapeptide-11
  • • Oligopeptide-54
  • • Oligopeptide-71
  • Phosphate buffered saline and excipients suitable for injectable use.

Formulation

  • Sterile, transparent, low-viscosity injectable gel.
  • Active complex: hyaluronic acid 0.7% + seven biomimetic peptides.
  • Intended for intradermal injection into the scalp at or near the level of the hair follicles.
  • For single use only; each syringe is pre-filled and sterile.

Packaging

  • Pack contains 2 x 1 ml sterile pre-filled glass syringes of Dr. CYJ Hair Filler.
  • Each syringe supplied in a sterile blister with tamper-evident packaging.
  • Outer carton printed with product name, batch number, expiry date, CE marking and manufacturer details.
  • Package includes Instructions for Use (IFU) for healthcare professionals.

Usage

  • For professional use only; must be administered by suitably qualified and trained medical practitioners experienced in injectable scalp treatments.
  • Before treatment, thoroughly disinfect the scalp area to be injected.
  • Inject Dr. CYJ Hair Filler into the superficial to mid-dermis of the scalp in the regions of hair thinning or damage, using an appropriate fine needle or multi-needle device (e.g. 30–32G, short length), following the IFU and local clinical protocols.
  • Standard in-clinic protocol commonly consists of 4 treatment sessions spaced approximately 2 weeks apart.
  • A consolidation phase may follow with around 3 additional sessions spaced about 1 month apart, depending on clinical judgement and patient response.
  • Injection points are usually spaced in a grid pattern over the affected area; care should be taken to inject small aliquots per point to ensure even distribution.
  • After treatment, patients are often advised to avoid washing the hair, using saunas/steam rooms, or intense physical exercise for a short period (for example 24–48 hours or as per clinic protocol).
  • Patients should follow all post-procedure instructions given by their practitioner, which may include avoiding alcohol, direct sun exposure or irritant hair products for several days.
  • Treatment can be repeated as necessary based on practitioner assessment to maintain or enhance results.

Contraindications

  • Known hypersensitivity or allergy to hyaluronic acid, any of the listed peptides or other components of the product.
  • Presence of active scalp infections, inflammatory scalp diseases or open wounds at the intended injection sites (e.g. folliculitis, severe seborrheic dermatitis, psoriasis flares).
  • Patients with a history of severe allergic reactions or anaphylaxis, unless carefully evaluated and deemed suitable by a physician.
  • Autoimmune diseases or immunosuppression, unless the treating physician judges that the benefits outweigh the risks.
  • Bleeding disorders or current use of anticoagulant / antiplatelet therapies where injection-related bleeding risk is unacceptable.
  • Pregnancy and breastfeeding (use is generally not recommended due to limited safety data).
  • Patients under 18 years of age.
  • Any other condition where the practitioner considers injectable treatment inappropriate or unsafe.

Adverse Effects

  • Typical injection-site reactions such as transient pain, tenderness, redness (erythema), swelling or itching at the treated areas.
  • Small bruises (ecchymosis) or haematomas at injection points.
  • Temporary scalp sensitivity or mild headache after treatment.
  • Local nodules or palpable irregularities, usually resolving spontaneously or with gentle massage and medical follow-up if needed.
  • Infection at injection sites if aseptic technique is not strictly observed.
  • Allergic or hypersensitivity reactions, including local or more diffuse inflammatory responses; treatment should be stopped and medical management initiated if suspected.
  • Very rare risk of more serious complications associated with injection procedures in general, such as vascular compromise; these require prompt recognition and appropriate medical intervention.

Storage Conditions

  • Store in a clean, dry place at controlled room temperature according to the range specified on the packaging (commonly between about 2°C and 25°C).
  • Do not freeze; protect from excessive heat and direct sunlight.
  • Keep the product in its original packaging until immediately before use to maintain sterility and protect from light.
  • Do not use if the packaging is damaged, if the solution is discoloured or contains particles, or after the expiry date indicated on the carton and syringe.
  • Single-use only – do not resterilise or reuse any syringe or remaining product.
  • Keep out of the sight and reach of children and unauthorised persons.

Duration

A typical treatment course consists of 4 sessions at 2-week intervals, followed by a consolidation phase of approximately 3 sessions at 1-month intervals. Results usually persist for several months after the full course; maintenance treatments may be recommended periodically, according to the patient\u2019s response and practitioner assessment.

Onset

Some improvement in hair quality and reduction in shedding may be noted within several weeks, with visible hair regrowth and increased density often becoming apparent after 2\u20133 months and continuing to improve over the course of treatment.

Browse more Medical Device \u2013 Injectable Hair Filler

Top Treatments

Top Cities in the UK